Shape 8.5 (EPT/RI) – Afh Monetary Crew Percent

Globe Newswire

Worldwide Autoimmune Disease Diagnosis Industry to 2026 – Key Players Include Abbott Laboratories, Aesku.Diagnostics and Beckman Coulter Among Others

Dublin, March 30, 2021 (GLOBE NEWSWIRE) — The “Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to’s offering. The global autoimmune disease diagnosis market reached a value of US$ 4.4 Billion in 2020. An autoimmune disease refers to a condition wherein the immune system attacks and destroys healthy cells, tissues, and organs of the body. In the longer run, it can also lead to abnormal growth of an organ and changes in organ function. Currently, more than 80 different autoimmune disorders have been identified by scientists, out of which Systemic Lupus Erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes, are the most common. Depending on the disorder, the doctor uses a combination of methods, which include a physical examination, medical history, blood tests, biopsy, and X-rays, to provide an effective diagnosis. They prescribe anti-inflammatory and immunosuppressant drugs, physical therapy, surgery, and injections, to control the overactive immune response and provide relief from symptoms.Owing to the rising prevalence of autoimmune diseases, healthcare professionals around the world are focusing on the adoption of advanced technologies to conduct multiple tests with faster and more precise results. Apart from this, a large number of research and diagnostics institutes are undertaking public awareness campaigns to educate individuals about autoimmune diseases and their possible treatments and diagnosis, which is positively influencing the market growth. Furthermore, several governing authorities, along with non-governing organizations, are funding various programs to develop novel therapeutics. For instance, the AMP RA/SLE Program, launched by the Accelerating Medicines Partnership (AMP), is a public-private partnership between the National Institutes of Health (NIH), the US Food and Drug Administration (FDA) and multiple non-profit organizations. The program aims to identify relevant drug targets for the treatment of autoimmune diseases. Looking forward, the publisher expects the global autoimmune disease diagnosis market to grow at a CAGR of 8.10% during 2021-2026.Breakup by Product Type: Consumables and Assay KitsInstruments Breakup by Disease Type: Systemic Autoimmune DiseaseRheumatoid ArthritisPsoriasisSystemic Lupus Erythematosus (SLE)Multiple SclerosisOthersLocalized Autoimmune DiseaseInflammatory Bowel DiseaseType 1 DiabetesThyroidOthers Breakup by Test Type: Routine Laboratory TestsInflammatory MarkersAutoantibodies and Immunologic TestsOthers Breakup by End-User: Clinical LaboratoriesHospitalsOthers Breakup by Region: North AmericaUnited StatesCanadaAsia PacificChinaJapanIndiaSouth KoreaAustraliaIndonesiaOthersEuropeGermanyFranceUnited KingdomItalySpainRussiaOthersLatin AmericaBrazilMexicoOthersMiddle East and Africa Competitive Landscape:The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Aesku.Diagnostics GmbH & Co. KG, Beckman Coulter Inc. (Danaher Corporation), bioMerieux SA (Institut Merieux), Bio-Rad Laboratories Inc., Euroimmun AG (PerkinElmer Inc.), Hemagen Diagnostics Inc., Inova Diagnostics Inc. (Werfen Group S.A.), Myriad Genetics Inc., Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens AG), SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech, etc.Key Questions Answered in This Report: How has the global autoimmune disease diagnosis market performed so far and how will it perform in the coming years?What are the key regional markets?What has been the impact of COVID-19 on the global autoimmune disease diagnosis market?What is the breakup of the market based on the product type?What is the breakup of the market based on the disease type?What is the breakup of the market based on the test type?What is the breakup of the market based on the end-user?What are the various stages in the value chain of the industry?What are the key driving factors and challenges in the industry?What is the structure of the global autoimmune disease diagnosis market and who are the key players?What is the degree of competition in the industry? Key Topics Covered: 1 Preface2 Scope and Methodology2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.3.1 Primary Sources2.3.2 Secondary Sources2.4 Market Estimation2.4.1 Bottom-Up Approach2.4.2 Top-Down Approach2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Autoimmune Disease Diagnosis Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast6 Market Breakup by Product Type6.1 Consumables and Assay Kits6.1.1 Market Trends6.1.2 Market Forecast6.2 Instruments6.2.1 Market Trends6.2.2 Market Forecast7 Market Breakup by Disease Type7.1 Systemic Autoimmune Disease7.1.1 Market Trends7.1.2 Market Breakup by Type7.1.2.1 Rheumatoid Arthritis7.1.2.2 Psoriasis7.1.2.3 Systemic Lupus Erythematosus (SLE) Multiple Sclerosis7.1.2.5 Others7.1.3 Market Forecast7.2 Localized Autoimmune Disease7.2.1 Market Trends7.2.2 Market Breakup by Type7.2.2.1 Inflammatory Bowel Disease7.2.2.2 Type 1 Diabetes7.2.2.3 Thyroid7.2.2.4 Others7.2.3 Market Forecast8 Market Breakup by Test Type8.1 Routine Laboratory Tests8.1.1 Market Trends8.1.2 Market Forecast8.2 Inflammatory Markers8.2.1 Market Trends8.2.2 Market Forecast8.3 Autoantibodies and Immunologic Tests8.3.1 Market Trends8.3.2 Market Forecast8.4 Others8.4.1 Market Trends8.4.2 Market Forecast9 Market Breakup by End-User9.1 Clinical Laboratories9.1.1 Market Trends9.1.2 Market Forecast9.2 Hospitals9.2.1 Market Trends9.2.2 Market Forecast9.3 Others9.3.1 Market Trends9.3.2 Market Forecast10 Market Breakup by Region10.1 North America10.2 Asia Pacific10.3 Europe10.4 Latin America10.5 Middle East and Africa11 SWOT Analysis11.1 Overview11.2 Strengths11.3 Weaknesses11.4 Opportunities11.5 Threats12 Value Chain Analysis13 Porters Five Forces Analysis13.1 Overview13.2 Bargaining Power of Buyers13.3 Bargaining Power of Suppliers13.4 Degree of Competition13.5 Threat of New Entrants13.6 Threat of Substitutes14 Competitive Landscape14.1 Market Structure14.2 Key Players14.3 Profiles of Key Players For more information about this report visit CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Add a Comment

Your email address will not be published. Required fields are marked *